PPARA and fatty liver disease: In addition, irisin leads to fibroblast growth factor-21 (FGF-21) upregulation through the PPAR signaling pathway, especially PPAR-α [22], which can subsequently improve insulin sensitivity and hepatic steatosis [22, 26].